Evaluation of the Accuracy of Fecal Immunochemical Testing for Colorectal Cancer Screening in an Average-Risk Population: A Prospective Study FIT Accuracy in CRC Screening
Article Sidebar
Main Article Content
Abstract
Background: Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Early detection through screening improves survival rates, particularly in average-risk populations. Fecal Immunochemical Testing (FIT) offers a non-invasive, cost-effective screening method that has gained widespread acceptance.
Objective: To evaluate the accuracy of FIT for CRC screening in an average-risk population.
Methods: This prospective observational study was conducted at Khyber Teaching Hospital, Peshawar, from January 2023 to December 2023. A total of 185 patients aged ≥18 years with average CRC risk were included. FIT was used to detect occult blood, and all participants underwent colonoscopy as the reference standard. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated, with data analysis performed using SPSS version 25.
Results: FIT demonstrated a sensitivity of 87.5%, specificity of 86.0%, PPV of 23.3%, and NPV of 99.0%. Among 185 patients, 3.8% had CRC, 8.1% had advanced adenomas, and 4.3% were false positives. One patient (0.5%) had a false negative result.
Conclusion: FIT is a highly effective and reliable screening tool for detecting CRC and advanced adenomas in average-risk populations, though follow-up colonoscopy is essential for positive results.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Katsoula A, Paschos P, Haidich A, Tsapas A, Giouleme O. Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-Analysis. JAMA Intern Med. 2017;177(8):1110–8. doi:10.1001/jamainternmed.2017.2309.
Fraser CG, Allison JE, Halloran SP, Young GP. A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin. J Natl Cancer Inst. 2012;104(11):810-4.
Castro I, Cubiella J, Rivera C, et al. Fecal Immunochemical Test Accuracy in Familial Risk Colorectal Cancer Screening. Int J Cancer. 2014;134(2):367-75.
Ng SC, Ching JY, Chan V, et al. Diagnostic Accuracy of Faecal Immunochemical Test for Screening Individuals With a Family History of Colorectal Cancer. Aliment Pharmacol Ther. 2013;38(7):835-41.
Otero-Estevez O, De Chiara L, Rodriguez-Berrocal FJ, et al. Serum sCD26 for Colorectal Cancer Screening in Family-Risk Individuals: Comparison With Faecal Immunochemical Test. Br J Cancer. 2015;112(2):375-81.
Robertson DJ, Lee JK, Boland CR, et al. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2016;151(5):1217-37.
Lin JS, Piper MA, Perdue LA, et al. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;315(23):2576-94.
Salimzadeh H, Bishehsari F, Amani M, et al. Advanced Colonic Neoplasia in the First Degree Relatives of Colon Cancer Patients: A Colonoscopy-Based Study. Int J Cancer. 2016;139(10):2243-51.
Berger BM, Parton MA, Levin B. USPSTF Colorectal Cancer Screening Guidelines: An Extended Look at Multi-Year Interval Testing. Am J Manag Care. 2016;22(2).
Hernandez V, Cubiella J, Gonzalez-Mao MC, et al. Fecal Immunochemical Test Accuracy in Average-Risk Colorectal Cancer Screening. World J Gastroenterol. 2014;20(4):1038-47. doi:10.3748/wjg.v20.i4.1038.
Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-Analysis. Ann Intern Med. 2014;160(3):171. doi:10.7326/M13-1484.
Doubeni CA, Corley DA, Jensen CD, et al. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024;7(7). doi:10.1001/jamanetworkopen.2024.23671.
Wolf AMD, Fontham ETH, Church TR, et al. Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-81. doi:10.3322/caac.21457.
Lu M, Luo X, Li N, Chen H, Dai M. Diagnostic Accuracy of Fecal Occult Blood Tests for Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review and Meta-Analysis. Clin Epidemiol. 2019;11:943-54. doi:10.2147/CLEP.S213677.
Levin TR, Corley DA, Jensen CD, et al. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018;155(5):1383-91.e5. doi:10.1053/j.gastro.2018.07.017.
Doubeni CA, Corley DA, Zhao W, Lau Y, Jensen CD, Levin TR. Association Between Improved Colorectal Screening and Racial Disparities. N Engl J Med. 2022;386(8):796-8. doi:10.1056/NEJMc2112409.
Chiu HM, Jen GH, Wang YW, et al. Long-Term Effectiveness of Faecal Immunochemical Test Screening for Proximal and Distal Colorectal Cancers. Gut. 2021;70(12):2321-9. doi:10.1136/gutjnl-2020-322545.
Baldacchini F, Bucchi L, Giuliani O, et al. Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study. Clin Gastroenterol Hepatol. 2022;20(10):2373-82. doi:10.1016/j.cgh.2022.01.053.
Forsberg A, Westerberg M, Metcalfe C, et al. Once-Only Colonoscopy or Two Rounds of Faecal Immunochemical Testing 2 Years Apart for Colorectal Cancer Screening (SCREESCO): Preliminary Report of a Randomised Controlled Trial. Lancet Gastroenterol Hepatol. 2022;7(6):513-21. doi:10.1016/S2468-1253(21)00473-8.
Robertson DJ, Dominitz JA, Beed A, et al. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial. JAMA Netw Open. 2023;6(7). doi:10.1001/jamanetworkopen.2023.21730.